🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

New consensus on assessing Primary Aldosteronism Medical treatment Outcomes (PAMO), and PAMO in 1258 patients from 28 centres around the world. Grateful to 54 co-authors for collaborating! Hudson Institute of Medical Research Endocrine Society of Australia Monash University School of Clinical Sciences A5_AdrenalAlliance Endocrine Society sciencedirect.com/science/articl…

A trial of #finerenone in treating #PrimaryAldosteronism. As expected, it was as good as spironolactone at lowering BP, without the adverse effects. Now we need a larger RCT. PrimaryAldosteronismOrg Endocrine Society of Australia Endocrine Society Hypertension Australia Hudson Institute of Medical Research ahajournals.org/doi/abs/10.116…

Primary Aldosteronism is very common This interactive case reviews how to recognize it, avoid pitfalls, and effectively help your patients NEJM nejm.org/doi/full/10.10… (free access with login)

Thromboprophylaxis in patients with endogenous Cushing's remains a hot topic. Our just released Position Statement is available at DOI: 10.1093/ejendo/lvaf017 Metabolism and Systems Science (MSS) Birmingham Health Partners European Society of Endocrinology (ESE) @PituitarySociety ENEA The Pituitary Foundation

Delighted to share perspective piece Circulation on history of resistant HTN with Adina Turcu In the US, it was 1st defined by JNC V report. Back then, RH need a diuretic+2 drugs: BB, vasodilator, CCB, or ACEI. We have come a long way! UTSW Heart tinyurl.com/3tttvaye

The evolution of resistant hypertension: from JNC V to AHA/ACC guidelines Adina Turcu Wanpen Vongpatanasin ahajournals.org/doi/full/10.11…

Looking forward to sharing stories on resurrecting orphan drugs for orphan endocrine diseases - searching for cures for ACC (adrenal cancer) & TED (thyroid eye disease) at the IGF & Insulin System Gordon Research Conference - April 16-21 lnkd.in/gGsyjyuR

It’s always about the team. Recent advancements in understanding homeostasis of adrenal focusing on stem/progenitor cells with a nod towards therapeutic innovations. Privileged to work with this amazing group of scientists & clinicians. Onward & upward. nature.com/articles/s4157…

Congratulations to the Michigan Medicine ThyCARE-Thyroid and Thyroid CAncer REsearch (Thyroid and Thyroid CAncer REsearch) team, led by Dr. Megan Haymart, on being selected to receive the inaugural AACE Endocrine Care Innovation Award! Learn more: medschool.umich.edu/departments/in…

Work smarter, not harder! A low renin with concurrent use of ACEi/ARB is almost certainly some shade of Primary Aldosteronism. Either way, aldosterone-directed therapy is very likely to provide major clinical benefits ahajournals.org/eprint/TUS6CGX… Cheng-Hsuan Tsai

Please join us in celebrating International Adrenal Awareness Day tomorrow, April 7th, 2025! #AdrenalDay2025 #InternationalAdrenalConsortium #Celebrate

Beautiful study by Alex Leung, MD MPH et al. Hopefully this will keep the momentum going for simplifying PA diagnosis and or empiric MR antagonist thearpy. acpjournals.org/doi/10.7326/AN…

New content online: Promising drugs for PCOS: targeting metabolic and endocrine dysfunctions bit.ly/43hOB5r

Outstanding talk here at Endocrine Society #ENDO2025 on adrenal Cushing genomics by University of Michigan adrenal team member Juilee Rege here at #ENDO2025 Go Juilee, Go Blue Go A5_AdrenalAlliance

Congratulations lead author NEJM publication Adina Turcu 👏👏 & coauthors👏 Exciting time for aldo field👏

Congratulations & interesting finding Harlan Krumholz & team in JAMA Network Open 👏👏 Timely for me to include for supporting evidence for my rebuttal Delayed #Hypertension Diagnosis & Cardiovascular Treatment & Outcomes jamanetwork.com/journals/jaman…

Good timing: Yulan’s review with lab colleagues on adrenocortical stem cell niche published during Endocrine Society #ENDO2025 and on the eve of her PhD defense. Nature Reviews Endocrinology post: Yulan Chu and colleagues outline the mechanisms that regulate the establishment and

Extremely exciting to share the new #PrimaryAldosteronism guidelines. Big advance in suggesting that all hypertensive adults should be screened for PA. Let's diagnose and treat every patient with this common, deleterious but highly treatable disease! PrimaryAldosteronismOrg Endocrine Society

Hats off to Lauren Fishbein - here at Endocrine Society #ENDO2025 who presented new data on modifier genes in paraganglioma-pheochromocytoma from GWAS studies with close to 2000 tumor samples from A5_AdrenalAlliance teams around the globe. New targets, new biology. Hope for new therapies!

So exciting to see the 10+ yr maturation of our outstanding network - over 50 institutions across 4 continents: A5_AdrenalAlliance 2025 meeting has begun - directly following the outstanding Endocrine Society #ENDO2025 meeting !!! Adrenophiles sharing great science to advance care.